Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Antibe Therapeutics Inc. (ATE)

Toronto
Currency in CAD
Disclaimer
0.29
0.00(0.00%)
Closed

ATE Comments

Take the L sell that sht
Antibe sux ass
It would have been nice to get the heads up yesterday
Wtf happened here?
time to sell
warrants, derisking before results
anybody knows why ATE is falling?
Buy out coming soon
Does anybody know why the stock ran up?
results of phase 2 study should be coming available soon...
results of phase 2 study should be coming available soon...
results of phase 2 study should be coming available soon...
up
I think its got way more travelling room to the north. but I'd wait for a pullback to enter. It has entered overbought territory.
Anyone looking on this stock
I had it in my paper account. disappointed I missed the hike
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.